Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 112
Filter
1.
Metabolism ; 121: 154801, 2021 08.
Article in English | MEDLINE | ID: mdl-34058224

ABSTRACT

OBJECTIVE: NAFLD is a complex disease marked by cellular abnormalities leading to NASH. NAFLD patients manifest low hepatic levels of CEACAM1, a promoter of insulin clearance. Consistently, Cc1-/- null mice displayed spontaneous hyperinsulinemia/insulin resistance and steatohepatitis. Liver-specific reconstitution of Ceacam1 reversed these metabolic anomalies in 8-month-old Cc1-/-xliver+ mice fed a regular chow diet. The current study examined whether it would also reverse progressive hepatic fibrosis in mice fed a high-fat (HF) diet. METHODS: 3-Month-old mice were fed a high-fat diet for 3-5 months, and metabolic and histopathological analysis were conducted to evaluate their NASH phenotype. RESULTS: Reconstituting CEACAM1 to Cc1-/- livers curbed diet-induced liver dysfunction and NASH, including macrovesicular steatosis, lobular inflammation, apoptosis, oxidative stress, and chicken-wire bridging fibrosis. Persistence of hepatic fibrosis in HF-fed Cc1-/- treated with nicotinic acid demonstrated a limited role for lipolysis and adipokine release in hepatic fibrosis caused by Ceacam1 deletion. CONCLUSIONS: Restored metabolic and histopathological phenotype of HF-fed Cc1-/-xliver+xliver+ assigned a critical role for hepatic CEACAM1 in preventing NAFLD/NASH including progressive hepatic fibrosis.


Subject(s)
Carcinoembryonic Antigen/physiology , Liver Cirrhosis/genetics , Animals , Carcinoembryonic Antigen/genetics , Diet, High-Fat , Insulin/metabolism , Insulin Resistance/genetics , Lipid Metabolism/genetics , Liver Cirrhosis/metabolism , Liver Cirrhosis/pathology , Male , Mice , Mice, Inbred C57BL , Mice, Knockout
2.
Drug Metab Dispos ; 47(11): 1240-1246, 2019 11.
Article in English | MEDLINE | ID: mdl-31533926

ABSTRACT

Carcinoembryonic antigen (CEA) is a tumor-specific antigen overexpressed in multiple cancers. CEA is expressed as a membrane protein, a part of which is cleaved from the cell membrane and secreted into blood. The soluble form of CEA (sCEA) has been shown to accelerate the clearance of anti-CEA antibody, which limits the antibody distribution in the tumor. To overcome this issue, we developed an anti-CEA monoclonal antibody, 15-1-32, which shows a strong affinity for membrane-bound CEA (mCEA) and relatively weak affinity for sCEA. In this study, we compared the effect of sCEA on the pharmacokinetics of 15-1-32 in mice with that of another anti-CEA monoclonal antibody, labetuzumab, showing less selectivity to mCEA than 15-1-32. As expected, the effect of sCEA on the serum concentration of 15-1-32 was much smaller than that of labetuzumab. The decrease in the area under the curve (AUC) of serum concentration was 22.5% for 15-1-32 when it was coadministered with sCEA, while that of labetuzumab was 79.9%. We also compared the pharmacokinetics of these two antibodies in CEA-positive tumor-bearing mice. The AUCs of 15-1-32 and labetuzumab were decreased in tumor-bearing mice compared with non-tumor-bearing mice to a similar extent (approximately 40% decrease). These results suggested that mCEA also contributes to the clearance of anti-CEA antibodies in CEA-positive tumor-bearing mice. Although the increased selectivity to mCEA minimized the effect of sCEA on the pharmacokinetics of 15-1-32, it may be insufficient to improve the pharmacokinetics in CEA-positive cancer patients. SIGNIFICANCE STATEMENT: Because previous studies reported the rapid clearance of anti-CEA antibodies mediated by soluble CEA, we obtained a monoclonal antibody, 15-1-32, selective to membrane-bound CEA and evaluated the effects of CEA on its pharmacokinetics. Although the effect of soluble CEA on the serum concentration of 15-1-32 was very small, the clearance of 15-1-32 in CEA-positive tumor-bearing mice was still rapid, suggesting membrane-bound CEA also contributes to the clearance of anti-CEA antibodies. These results indicated that increasing selectivity to membrane-bound CEA is not enough to improve the pharmacokinetics of anti-CEA antibody.


Subject(s)
Antibodies, Monoclonal/pharmacokinetics , Carcinoembryonic Antigen/immunology , Animals , Antibodies, Monoclonal, Humanized/pharmacokinetics , Area Under Curve , Carcinoembryonic Antigen/physiology , Liver/metabolism , Male , Mice , Mice, Inbred BALB C
3.
Med Sci Monit ; 23: 3593-3602, 2017 Jul 24.
Article in English | MEDLINE | ID: mdl-28736431

ABSTRACT

BACKGROUND Glioblastoma multiforme (GBM) evades immune surveillance by inducing immunosuppression via receptor-ligand interactions between immune checkpoint molecules. T cell immunoglobulin and mucin domain 3 (Tim-3) is a key checkpoint receptor responsible for exhaustion and dysfunction of T cells and plays a critical role in immunosuppression. Carcinoembryonic antigen-related cell adhesion molecule 1 (CEACAM1) has been recently identified as a heterophilic ligand for Tim-3. MATERIAL AND METHODS We established an intracranial GBM model using C57BL/6 mice and GL261 cells, and treated the mice with single or combined monoclonal antibodies (mAbs) against Tim-3/CEACAM1. The CD4+, CD8+, and regulatory T cells in brain-infiltrating lymphocytes were analyzed using flow cytometry, and the effector function of T cells was assessed using ELISA. We performed a rechallenge by subcutaneous injection of GL261 cells in the "cured" (>90 days post-orthotopic tumor implantation) and naïve mice. RESULTS The mean survival time in the control, anti-Tim-3, anti-CEACAM1, and combined treatment groups was 29.8, 43.4, 42.3, and 86.0 days, respectively, with 80% of the mice in the combined group becoming long-term survivors showing immune memory against glioma cells. Infiltrating CD4+ and CD8+ T cells increased and immunosuppressive Tregs decreased with the combined therapy, which resulted in a markedly elevated ratio of CD4+ and CD8+ cells to Tregs. Additionally, plasma IFN-γ and TGF-ß levels were upregulated and downregulated, respectively. CONCLUSIONS Our data indicate that combined blockade of Tim-3 and CEACAM1 generates robust therapeutic efficacy in mice with intracranial tumors, and provides a promising option for GBM immunotherapy.


Subject(s)
Carcinoembryonic Antigen/therapeutic use , Glioma/pathology , Hepatitis A Virus Cellular Receptor 2/physiology , Hepatitis A Virus Cellular Receptor 2/therapeutic use , Animals , Antibodies, Monoclonal/therapeutic use , Antilymphocyte Serum/therapeutic use , Brain Neoplasms/metabolism , CD8-Positive T-Lymphocytes/immunology , Carcinoembryonic Antigen/metabolism , Carcinoembryonic Antigen/physiology , Disease Models, Animal , Glioblastoma , Glioma/drug therapy , Hepatitis A Virus Cellular Receptor 2/metabolism , Immune Tolerance/immunology , Immunotherapy , Mice , Mice, Inbred C57BL , Receptors, Virus/metabolism , Transforming Growth Factor beta/metabolism , Treatment Outcome
4.
Eur J Radiol ; 92: 64-71, 2017 Jul.
Article in English | MEDLINE | ID: mdl-28624022

ABSTRACT

OBJECTIVES: CT texture analysis has shown promise to differentiate colorectal cancer patients with/without hepatic metastases. AIM: To investigate whether whole-liver CT texture analysis can also predict the development of colorectal liver metastases. MATERIAL AND METHODS: Retrospective multicentre study (n=165). Three subgroups were assessed: patients [A] without metastases (n=57), [B] with synchronous metastases (n=54) and [C] who developed metastases within ≤24 months (n=54). Whole-liver texture analysis was performed on primary staging CT. Mean grey-level intensity, entropy and uniformity were derived with different filters (σ0.5-2.5). Univariable logistic regression (group A vs. B) identified potentially predictive parameters, which were tested in multivariable analyses to predict development of metastases (group A vs. C), including subgroup analyses for early (≤6 months), intermediate (7-12 months) and late (13-24 months) metastases. RESULTS: Univariable analysis identified uniformity (σ0.5), sex, tumour site, nodal stage and carcinoembryonic antigen as potential predictors. Uniformity remained a significant predictor in multivariable analysis to predict early metastases (OR 0.56). None of the parameters could predict intermediate/late metastases. CONCLUSIONS: Whole-liver CT-texture analysis has potential to predict patients at risk of developing early liver metastases ≤6 months, but is not robust enough to identify patients at risk of developing metastases at later stage.


Subject(s)
Carcinoembryonic Antigen/physiology , Colonic Neoplasms/diagnostic imaging , Liver Neoplasms/diagnostic imaging , Liver Neoplasms/pathology , Tomography, X-Ray Computed/methods , Adult , Colonic Neoplasms/pathology , Female , Humans , Male , Middle Aged , Retrospective Studies
5.
Zhonghua Wei Chang Wai Ke Za Zhi ; 20(4): 443-449, 2017 Apr 25.
Article in Chinese | MEDLINE | ID: mdl-28440527

ABSTRACT

OBJECTIVE: To explore the predictive value of combination detection of Pgp1 expression in cancer tissue and serum CEA level for the prognosis of colorectal cancer (CRC) patients. METHODS: Clinicopathological data, complete 5-year follow-up data and CRC tissue samples of 153 CRC patients with stage I( to II( tumor undergoing radical operation in our department from January 2004 to August 2006 were retrospectively collected. Immunohistochemical staining was used to detect the expression level of Pgp1. The combined evaluation of staining intensity and positive cell percentage was performed to determine the expression level of Pgp1. Pgp1 staining (-) and (+) was defined as low expression; and staining (++) and (+++) as high expression. Electrochemiluminescence immunoassay was used to detect the level of serum CEA. CEA > 5 µg/L was defined as positive. χ2 and Fisher's exact test were performed to analyze the association of Pgp1 expression with CEA level and clinicopathological variables. Moreover, Kaplan-Meier method was used to analyze the survival. Univariate and multivariate Cox proportional hazard regression models were used to evaluate the roles of Pgp1 expression combined with serum CEA level in prognosis prediction. RESULTS: Of 153 patients, 105 were males and 48 females with mean age of 59 (27 to 90) years; 41 cases were rectal cancer, and 112 cases colon cancer; 23 patients were TNM stage I( tumor, and 130 patients stage II( tumor; median follow-up time was 64 months; 30 cases were dead. Positive rate of Pgp1 expression in colorectal cancer tissues was 66.0%(101/153). The expression of Pgp1 was associated with gender, tumor location, and survival during the follow-up (all P<0.05). The preoperative positive rate of serum CEA was 28.1% (43/153). The preoperative serum CEA level was associated with tumor recurrence and survival (all P<0.05). Kaplan-Meier analysis showed the overall 5-year survival rate was 81.7%. The 5-year survival rate of patients with high expression of Pgp1 was 88.1%, which was significantly higher than 69.2% of those with low expression of Pgp1(P=0.003). The 5-year survival rate of patients with preoperative positive serum CEA was 72.1%, which was significantly lower than 86.1% of those with preoperative negative serum CEA(P=0.023). Furthermore, the 5-year survival rate of patients with negative Pgp1 plus positive CEA was 66.7%, which was significantly lower than 91.0% of those with positive Pgp1 plus negative CEA(P=0.002). Univariate analysis showed that gender, Pgp1 expression level, preoperative serum CEA level, and Pgp1 combined with CEA were significantly associated with the prognosis of patients(all P<0.05). Multivariate analysis showed that Pgp1 expression was an independent prognostic factor of CRC [HR(95%CI:1.261 to 64.224), P=0.028]. CONCLUSIONS: Low expression of Pgp1 in cancer tissue indicates poor prognosis in patients with stage I( and II( tumor. Combination detection of Pgp1 expression and serum CEA can be applied to predict the prognosis of patients with stage I( and II( colorectal cancer.


Subject(s)
Biomarkers, Tumor/physiology , Carcinoembryonic Antigen/physiology , Colonic Neoplasms/metabolism , Colonic Neoplasms/physiopathology , Colorectal Neoplasms/metabolism , Colorectal Neoplasms/physiopathology , Hyaluronan Receptors/metabolism , Neoplasm Proteins/physiology , Neoplasm Recurrence, Local/physiopathology , Predictive Value of Tests , Rectal Neoplasms/metabolism , Rectal Neoplasms/physiopathology , Survival Rate , Adult , Aged , Aged, 80 and over , Biomarkers, Tumor/blood , Carcinoembryonic Antigen/blood , Female , Fluorescent Antibody Technique , Humans , Kaplan-Meier Estimate , Male , Middle Aged , Multivariate Analysis , Neoplasm Proteins/blood , Neoplasm Staging , Prognosis , Proportional Hazards Models , Retrospective Studies , Sex Factors
6.
J Lipid Res ; 57(12): 2163-2175, 2016 12.
Article in English | MEDLINE | ID: mdl-27777319

ABSTRACT

Carcinoembryonic antigen-related cell adhesion molecule 1 (CEACAM1) regulates insulin sensitivity by promoting hepatic insulin clearance and mediating suppression of fatty acid synthase activity. Feeding C57BL/6J male mice with a high-fat (HF) diet for 3-4 weeks triggered a >60% decrease in hepatic CEACAM1 levels to subsequently impair insulin clearance and cause systemic insulin resistance and hepatic steatosis. This study aimed at investigating whether lipolysis drives reduction in hepatic CEACAM1 and whether this constitutes a key mechanism leading to diet-induced metabolic abnormalities. Blocking lipolysis with a daily intraperitoneal injection of nicotinic acid in the last two days of a 30-day HF feeding regimen demonstrated that white adipose tissue (WAT)-derived fatty acids repressed hepatic CEACAM1-dependent regulation of insulin and lipid metabolism in 3-month-old male C57BL/6J mice. Adenoviral-mediated CEACAM1 redelivery countered the adverse metabolic effect of the HF diet on insulin resistance, hepatic steatosis, visceral obesity, and energy expenditure. It also reversed the effect of HF diet on inflammation and fibrosis in WAT and liver. This assigns a causative role for lipolysis-driven decrease in hepatic CEACAM1 level and its regulation of insulin and lipid metabolism in sustaining systemic insulin resistance, hepatic steatosis, and other abnormalities associated with excessive energy supply.


Subject(s)
Adipocytes/metabolism , Carcinoembryonic Antigen/physiology , Fatty Acids/metabolism , Hepatocytes/metabolism , Adipose Tissue, White/drug effects , Adipose Tissue, White/metabolism , Adipose Tissue, White/pathology , Animals , Cells, Cultured , Diet, High-Fat/adverse effects , Energy Metabolism , Fibrosis , Insulin Resistance , Lipid Metabolism , Male , Mice, Inbred C57BL , Niacin/pharmacology , Obesity/etiology , Obesity/metabolism
7.
Zhonghua Kou Qiang Yi Xue Za Zhi ; 51(1): 36-41, 2016 Jan.
Article in Chinese | MEDLINE | ID: mdl-26792186

ABSTRACT

OBJECTIVE: To investigate the effects of long chain non-coding RNA urothelial carcinoembryonic antigen 1(UCA1) on invasion, migration and proliferation abilities in oral squamous cell carcinoma cell lines SCC15 and CAL27. METHODS: Small interfering RNA of UCA1(UCA1-siRNA) was transfected into SCC15 and CAL27 cell lines by Lipofectamine(TM) 3000 to silence UCA1 , and transfected negtive control si-RNA served as a control. The effect of UCA1-siRNA was detected by quantitative real time-polymerase chain reaction(qRT-PCR) to confirm the successful inhibition of UCA1 by siRNA. The matrix metalloproteinase 9(MMP-9) protein level was detected by Western blotting analysis. The effect of siRNA on cell proliferation and invasion was assessed by transwell migration assay and wound healing assay. Cell counting kit-8(CCK-8) assay was carried out to estimate the proliferation of two cell lines with different expression levels of UCA1. RESULTS: Expressions of UCA1 of SCC15 and CAL27 were successfully suppressed after transfected with siRNA which verified by qRT-PCR, and the efficiency of downregulation of SCC15 and CAL27 was 86.45%(P<0.001)and 78.24%(P<0.001), respectively. The migration, invasion and proliferation of SCC15 and CAL27 cell lines after transfected with siRNA were obviously restrained. The number of migration and invasion of CAL27 cells were 719.20±92.36 versus 208.00±25.58 (P=0.000 7) and 363.40 ± 45.96 versus 164.80 ± 24.68(P= 0.005 2), respectively, the number of migration and invasion of SCC15 cells were 437.20±54.75 vs 145.80±23.31(P=0.001 1) and 249.80±38.41 vs 63.80±11.11 (P=0.001 6), respectively (UCA1-si compare to negtive control), the relative proliferation rates of SCC15 and CAL27 were SCC15: R24 h=0.870, R48 h=0.863, R72 h=0.64, R96 h=0.732; CAL27: R24 h=0.913, R48 h=0.829, R72 h=0.756, R96 h= 0.705(P<0.05), and MMP-9 expression level was decreased by UCA1-siRNA compared with negative control. CONCLUSIONS: UCA1 could enhance the ability of invasion and migration of SCC15 and CAL27 cell lines via regulating MMP-9 protein expression, which suggests that UCA1 might play a pivotal role in oral squamous cell carcinoma invasion and progression.


Subject(s)
Carcinoembryonic Antigen/physiology , Carcinoma, Squamous Cell/pathology , Cell Movement , Cell Proliferation/physiology , Matrix Metalloproteinase 9/metabolism , Mouth Neoplasms/pathology , Neoplasm Invasiveness , RNA, Small Interfering , Transfection , Carcinoembryonic Antigen/genetics , Carcinoma, Squamous Cell/enzymology , Cell Line, Tumor , Cell Migration Inhibition , Down-Regulation , Humans , Matrix Metalloproteinase 9/analysis , Mouth Neoplasms/enzymology , RNA, Long Noncoding , Transcellular Cell Migration
8.
Cancer Res ; 75(19): 4224-34, 2015 Oct 01.
Article in English | MEDLINE | ID: mdl-26238781

ABSTRACT

Glioblastoma-initiating cells (GIC) are a tumorigenic cell subpopulation resistant to radiotherapy and chemotherapy, and are a likely source of recurrence. However, the basis through which GICs are maintained has yet to be elucidated in detail. We herein demonstrated that the carcinoembryonic antigen-related cell adhesion molecule Ceacam1L acts as a crucial factor in GIC maintenance and tumorigenesis by activating c-Src/STAT3 signaling. Furthermore, we showed that monomers of the cytoplasmic domain of Ceacam1L bound to c-Src and STAT3 and induced their phosphorylation, whereas oligomerization of this domain ablated this function. Our results suggest that Ceacam1L-dependent adhesion between GIC and surrounding cells play an essential role in GIC maintenance and proliferation, as mediated by signals transmitted by monomeric forms of the Ceacam1L cytoplasmic domain.


Subject(s)
Antigens, CD/physiology , Carcinoembryonic Antigen/physiology , Cell Adhesion Molecules/physiology , Glioblastoma/pathology , Neoplasm Proteins/physiology , Neoplastic Stem Cells/pathology , STAT3 Transcription Factor/physiology , Signal Transduction/physiology , Animals , Astrocytoma/metabolism , Biomarkers, Tumor , Brain Neoplasms/blood supply , Brain Neoplasms/metabolism , Brain Neoplasms/pathology , CSK Tyrosine-Protein Kinase , Cell Division , Cell Self Renewal/genetics , Gene Expression Profiling , Glioblastoma/blood supply , Humans , Kaplan-Meier Estimate , Mice , Neovascularization, Pathologic/physiopathology , Phosphorylation , Polymerization , Protein Interaction Mapping , Protein Processing, Post-Translational , Protein Structure, Tertiary , Stem Cell Niche , Structure-Activity Relationship , Tumor Cells, Cultured , Tumor Stem Cell Assay , src-Family Kinases/physiology
9.
Nat Commun ; 6: 6217, 2015 Feb 18.
Article in English | MEDLINE | ID: mdl-25692415

ABSTRACT

B cells are essential for antiviral immune defence because they produce neutralizing antibodies, present antigen and maintain the lymphoid architecture. Here we show that intrinsic signalling of CEACAM1 is essential for generating efficient B-cell responses. Although CEACAM1 exerts limited influence on the proliferation of B cells, expression of CEACAM1 induces survival of proliferating B cells via the BTK/Syk/NF-κB-axis. The absence of this signalling cascade in naive Ceacam1(-/-) mice limits the survival of B cells. During systemic infection with cytopathic vesicular stomatitis virus, Ceacam1(-/-) mice can barely induce neutralizing antibody responses and die early after infection. We find, therefore, that CEACAM1 is a crucial regulator of B-cell survival, influencing B-cell numbers and protective antiviral antibody responses.


Subject(s)
Antibodies, Viral/immunology , B-Lymphocytes/cytology , Carcinoembryonic Antigen/physiology , Animals , Antibodies, Neutralizing/immunology , B-Lymphocytes/immunology , Bone Marrow/metabolism , Bone Marrow Cells/cytology , Cell Differentiation , Cell Proliferation , Cell Separation , Cell Survival , Flow Cytometry , Gene Expression Regulation , Immunoglobulin G/immunology , Mice , Mice, Inbred C57BL , Mice, Transgenic , Phosphorylation , Signal Transduction , Spleen/metabolism , Vesiculovirus
10.
Exp Cell Res ; 324(2): 115-23, 2014 Jun 10.
Article in English | MEDLINE | ID: mdl-24726916

ABSTRACT

Oncomarkers play important roles in the detection and management of human malignancies. Carcinoembryonic antigen (CEA, CEACAM5) and epithelial cadherin (E-cadherin) are considered as independent tumor markers in monitoring metastatic colorectal cancer. They are both expressed by cancer cells and can be detected in the blood serum. We investigated the effect of CEA production by MIP101 colorectal carcinoma cell lines on E-cadherin adherens junction (AJ) protein complexes. No direct interaction between E-cadherin and CEA was detected; however, the functional relationships between E-cadherin and its AJ partners: α-, ß- and p120 catenins were impaired. We discovered a novel interaction between CEA and beta-catenin protein in the CEA producing cells. It is shown in the current study that CEA overexpression alters the splicing of p120 catenin and triggers the release of soluble E-cadherin. The influence of CEA production by colorectal cancer cells on the function of E-cadherin junction complexes may explain the link between the elevated levels of CEA and the increase in soluble E-cadherin during the progression of colorectal cancer.


Subject(s)
Adherens Junctions/metabolism , Carcinoembryonic Antigen/physiology , Colorectal Neoplasms/pathology , Adherens Junctions/genetics , Adherens Junctions/pathology , Caco-2 Cells , Cadherins/metabolism , Cell Adhesion Molecules/genetics , Cell Adhesion Molecules/metabolism , Colorectal Neoplasms/genetics , Colorectal Neoplasms/metabolism , Disease Progression , HT29 Cells , Humans , Membrane Proteins/genetics , Membrane Proteins/metabolism , Protein Binding , beta Catenin/metabolism
11.
Hypertension ; 62(2): 317-23, 2013 Aug.
Article in English | MEDLINE | ID: mdl-23734002

ABSTRACT

The carcinoembryonic antigen-related cell adhesion molecule 1 regulates insulin sensitivity by promoting hepatic insulin clearance. Mice bearing a null mutation of Ceacam1 gene (Cc1(-/-)) develop impaired insulin clearance followed by hyperinsulinemia and insulin resistance, in addition to visceral obesity and increased plasma fatty acids. Because insulin resistance is associated with increased blood pressure, we investigated whether they develop higher blood pressure with activated renal renin-angiotensin system and whether this is mediated, in part, by the upregulation of renal (pro)renin receptor (PRR) expression. Compared with age-matched wild-type littermates, Cc1(-/-) mice exhibited increased blood pressure with increased activation of renal renin-angiotensin systems and renal PRR expression. Cytoplasmic and nuclear immunostaining of phospho-PI3K p85α and phospho-Akt was enhanced in the kidney of Cc1(-/-) mice. In murine renal inner medullary collecting duct epithelial cells with lentiviral-mediated small hairpin RNA knockdown of carcinoembryonic antigen-related cell adhesion molecule 1, PRR expression was upregulated and phosphorylation of PI3K (Tyr508), Akt (Ser473), NF-κB p65 (Ser276), cAMP response element-binding protein/activated transcription factor (ATF)-1 (Ser133), and ATF-2 (Thr71) was enhanced. Inhibiting PI3K with LY294002 or Akt with Akt inhibitor VIII attenuated PRR expression. In conclusion, global null deletion of Ceacam1 caused an increase in blood pressure with increased renin-angiotensin system activation together with upregulation of PRR via PI3K-Akt activation of cAMP response element-binding protein 1, ATF-1, ATF-2, and NF-κB p65 transcription factors.


Subject(s)
Carcinoembryonic Antigen/physiology , Cyclic AMP Response Element-Binding Protein/physiology , Phosphatidylinositol 3-Kinases/physiology , Proto-Oncogene Proteins c-akt/physiology , Receptors, Cell Surface/physiology , Signal Transduction/physiology , Transcription Factor RelA/physiology , Activating Transcription Factor 1/metabolism , Animals , Hypertension/etiology , Insulin Resistance , Male , Mice , Mice, Inbred C57BL , Prorenin Receptor
12.
Respiration ; 86(3): 216-23, 2013.
Article in English | MEDLINE | ID: mdl-23258197

ABSTRACT

BACKGROUND: Natural killer (NK) cells are lymphocytes of the innate immune system that play a crucial role in tumor immune surveillance. Accumulated data indicated that NK cells in the tumor microenvironment often display a suppressed function. However, the mechanism is not clear. OBJECTIVE: In this study, the effects and relative mechanisms of malignant pleural effusion (MPE) from patients with lung cancer on NK cells were researched. METHODS: MPE and peripheral blood (PB) samples were collected from patients with lung cancer. The cytotoxic activity of CD56(dim) NK cells in PB and MPE mononuclear cells was analyzed by flow cytometry. RESULTS: It was observed that the percentages of total NK cells and a CD56(dim) NK subset in MPE reduced accompanying impaired cytotoxic activity compared with that in paired PB. Cell-free MPE treatment reduced both the proportion and cytotoxic activity of CD56(dim) NK cells in PB from healthy donors. The suppression effects were not based on soluble carcinoembryonic antigen and the inhibitory cytokines interleukin-10 and transforming growth factor-ß1, but were dependent on the factor with a molecular weight >100 kDa. CONCLUSIONS: These results demonstrated that native soluble carcinoembryonic antigen does not suppress the activity of NK cells, and an unknown factor with a molecular weight >100 kDa plays a critical role in the impairment of CD56(dim) NK cells in MPE, which might lead to tumor progression.


Subject(s)
CD56 Antigen , Carcinoembryonic Antigen , Killer Cells, Natural/physiology , Pleural Effusion, Malignant/immunology , Adult , Aged , Aged, 80 and over , CD56 Antigen/metabolism , Carcinoembryonic Antigen/physiology , Disease Progression , Female , Humans , Interleukin-10/physiology , Killer Cells, Natural/metabolism , Killer Cells, Natural/pathology , Male , Middle Aged , Pleural Effusion, Malignant/metabolism , Pleural Effusion, Malignant/pathology , Transforming Growth Factor beta1/physiology
13.
Oncogene ; 32(7): 849-60, 2013 Feb 14.
Article in English | MEDLINE | ID: mdl-22469976

ABSTRACT

Liver metastasis is the predominant cause of colorectal cancer (CRC)-related mortality in developed countries. Carcinoembryonic antigen-related cell adhesion molecule 1 (CEACAM1) is a cell adhesion molecule with reduced expression in early phases of CRC development and thus functions as a tumor growth inhibitor. However, CEACAM1 is upregulated in metastatic colon cancer, suggesting a bimodal role in CRC progression. To investigate the role of this protein in the host metastatic environment, Ceacam1(-/-) mice were injected intrasplenically with metastatic MC38 mouse CRC cells. A significant reduction in metastatic burden was observed in Ceacam1(-/-) compared with wild-type (WT) livers. Intravital microscopy showed decreased early survival of MC38 cells in Ceacam1(-/-) endothelial environment. Metastatic cell proliferation within the Ceacam1(-/-) livers was also diminished. Bone marrow-derived cell recruitment, attenuation of immune infiltrates and diminished CCL2, CCL3 and CCL5 chemokine production participated in the reduced Ceacam1(-/-) metastatic phenotype. Transplantations of WT bone marrow (BM) into Ceacam1(-/-) mice fully rescued metastatic development, whereas Ceacam1(-/-) BM transfer into WT mice showed reduced metastatic burden. Chimeric immune cell profiling revealed diminished recruitment of CD11b(+)Gr1(+) myeloid-derived suppressor cells (MDSCs) to Ceacam1(-/-) metastatic livers and adoptive transfer of MDSCs confirmed the involvement of these immune cells in reduction of liver metastasis. CEACAM1 may represent a novel metastatic CRC target for treatment.


Subject(s)
Carcinoembryonic Antigen/physiology , Carcinoma/pathology , Colorectal Neoplasms/pathology , Animals , Carcinoembryonic Antigen/genetics , Carcinoembryonic Antigen/metabolism , Carcinoma/blood supply , Carcinoma/genetics , Cell Proliferation , Cell Survival , Colorectal Neoplasms/blood supply , Colorectal Neoplasms/genetics , Liver/metabolism , Liver/pathology , Mice , Mice, Knockout , Models, Biological , Neoplasm Metastasis , Neovascularization, Pathologic/genetics , Organ Specificity/genetics , Tumor Cells, Cultured
14.
FASEB J ; 26(6): 2648-56, 2012 Jun.
Article in English | MEDLINE | ID: mdl-22415308

ABSTRACT

After separating from a primary tumor, metastasizing cells enter the circulatory system and interact with host cells before lodging in secondary organs. Previous studies have implicated the surface glycoproteins CD44 and carcinoembryonic antigen (CEA) in adhesion, migration, and invasion, suggesting that they may influence metastatic progression. To elucidate the role of these multifunctional molecules while avoiding the potential drawbacks of ectopic expression or monoclonal antibody treatments, we silenced the expression of CD44 and/or CEA in LS174T colon carcinoma cells and analyzed their ability to metastasize in 2 independent mouse models. Quantitative PCR revealed that CD44 knockdown increased lung and liver metastasis >10-fold, while metastasis was decreased by >50% following CEA knockdown. These findings were corroborated by in vitro experiments assessing the metastatic potential of LS174T cells. Cell migration was decreased as a result of silencing CEA but was enhanced in CD44-knockdown cells. In addition, CD44 silencing promoted homotypic aggregation of LS147T cells, a phenotype that was reversed by additional CEA knockdown. Finally, CD44-knockdown cells exhibited greater mechanical compliance than control cells, a property that correlates with increased metastatic potential. Collectively, these data indicate that CEA, but not CD44, is a viable target for therapeutics aimed at curbing colon carcinoma metastasis.


Subject(s)
Carcinoembryonic Antigen/physiology , Colonic Neoplasms/pathology , Hyaluronan Receptors/physiology , Neoplasm Metastasis/physiopathology , Animals , Cell Movement/physiology , Colonic Neoplasms/physiopathology , Gene Knockdown Techniques , Gene Silencing , Humans , Liver Neoplasms/secondary , Lung Neoplasms/secondary , Mice , Tumor Cells, Cultured
15.
Br J Cancer ; 105(2): 239-45, 2011 Jul 12.
Article in English | MEDLINE | ID: mdl-21712823

ABSTRACT

BACKGROUND: Early diagnosis represents the best opportunity for cure of colorectal cancer. Current screening programmes use faecal occult blood testing for screening, which has limited sensitivity and poor specificity. METHODS: In this study we looked at a series of previously described diagnostic markers utilising circulating free DNA (cfDNA), with a preparation method allowing small DNA fragments to be isolated. The Circulating free DNA was isolated from samples obtained from 85 patients, including 35 patients without endoscopic abnormality, a group of 26 patients with benign colorectal adenomas, and 24 patients with colorectal carcinomas. In each case, polymerase chain reaction (PCR) was performed for Line1 79 bp, Line1 300 bp, Alu 115 bp, Alu 247 bp, and mitochondrial primers. In addition, carcinoembryonic antigen (CEA) was measured by ELISA. Each marker was analysed between normal, polyp, and cancer populations, and the best performing analysed in combination by logistic regression. RESULTS: The best model was able to discriminate normal from populations with adenoma or carcinoma using three DNA markers and CEA, showing an area under the receiver operator characteristic (ROC) curve of 0.855 with a positive predictive value of 81.1% for polyps and cancer diagnosis. CONCLUSION: These circulating markers in combination with other markers offer the prospect of a simple blood test as a possible secondary screen for colorectal cancers and polyps in patients with positive faecal occult blood tests.


Subject(s)
Biomarkers, Tumor/blood , Carcinoma/diagnosis , Colon , Colonic Polyps/diagnosis , Colorectal Neoplasms/diagnosis , Adenoma/blood , Adenoma/diagnosis , Adult , Aged , Aged, 80 and over , Biomarkers, Tumor/analysis , Biomarkers, Tumor/physiology , Carcinoembryonic Antigen/analysis , Carcinoembryonic Antigen/blood , Carcinoembryonic Antigen/physiology , Carcinoma/blood , Colon/metabolism , Colon/pathology , Colonic Polyps/blood , Colorectal Neoplasms/blood , Diagnosis, Differential , Female , Health , Humans , Male , Middle Aged , Young Adult
16.
Immunity ; 33(4): 620-31, 2010 Oct 29.
Article in English | MEDLINE | ID: mdl-21029969

ABSTRACT

Although carcinoembryonic antigen-related cell adhesion molecule-1 (CEACAM1) is an activation marker for neutrophils and delays neutrophil apoptosis, the role of CEACAM1 in granulopoiesis and neutrophil-dependent host immune responses has not been investigated. CEACAM1 expression correlated with granulocytic differentiation, and Ceacam1(-/-) mice developed neutrophilia because of loss of the Src-homology-phosphatase-1 (SHP-1)-dependent inhibition of granulocyte colony-stimulating factor receptor (G-CSFR) signal transducer and activator of transcription (Stat3) pathway provided by CEACAM1. Moreover, Ceacam1(-/-) mice were hypersensitive to Listeria Monocytogenes (LM) infection with an accelerated mortality. Reintroduction of CEACAM1 into Ceacam1(-/-) bone marrow restored normal granulopoiesis and host sensitivity to LM infection, while mutation of its immunoreceptor tyrosine-based inhibitory motifs (ITIMs) abrogated this restoration. shRNA-mediated reduction of Stat3 amounts rescued normal granulopoiesis, attenuating host sensitivity to LM infection in Ceacam1(-/-) mice. Thus, CEACAM1 acted as a coinhibitory receptor for G-CSFR regulating granulopoiesis and host innate immune response to bacterial infections.


Subject(s)
Carcinoembryonic Antigen/physiology , Granulocytes/physiology , Leukopoiesis , Receptors, Granulocyte Colony-Stimulating Factor/antagonists & inhibitors , Animals , Cell Lineage , Cell Proliferation , Mice , Mice, Inbred C57BL , Protein Tyrosine Phosphatase, Non-Receptor Type 6/metabolism , RNA, Small Interfering/genetics , STAT3 Transcription Factor/physiology , Signal Transduction
17.
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi ; 26(6): 525-9, 2010 Jun.
Article in Chinese | MEDLINE | ID: mdl-20487641

ABSTRACT

AIM: To evaluate the inhibitory effect of lymphocytes activated by the superantigen of toxic shock syndrome toxin-1 (TSST-1), which is regulated synergistically by 5 copies of hypoxia-responsive element (5HRE) and promoter of carcino-embryonic antigen (CEAp), against the carcino-embryonic antigen (CEA)-positive human colon carcinoma cell line LoVo under hypoxia condition in vitro. METHODS: The eukaryotic expressive vector was constructed with the transmembrane superantigen gene of 5HRE-CEAp-regulated TSST-1-linker-CD80TM, and was transfected into CEA-positive human colon carcinoma cell line LoVo and CEA-negative human cervical carcinoma cell line HeLa by Lipofectamine 2000. Stably transfected cell lines were selected by G418. RT-PCR was employed to examine the expression of TC mRNA. Peripheral blood lymphocytes(PBL) of healthy people were extracted and then activated by the lysates of tumor cells stably transfected with TC. Concurrently, PBL were cultured together with stably transfected tumor cells in order to kill these cells. Then the proliferative effect of TSST-1 on PBL, and the killing effect of PBL against the stably transfected tumor cells were detected by MTT. RESULTS: Monoclonal LoVo and HeLa cells stably transfected with TC were successfully obtained. Expression of TC mRNA in monoclonal LoVo cells under hypoxia condition was significantly higher than those under normoxia condition as confirmed by RT-PCR. Monoclonal HeLa cells did not express TC under either hypoxia condition or normoxia condition. As is shown by MTT assay, TSST-1 expressed by the monoclonal LoVo cells could effectively activate PBL to proliferate under hypoxia condition, resulting in dose-dependent inhibition on the proliferation of LoVo cells that expressed TSST (P<0.05). But HeLa cells and wild LoVo cells could not activate PBL to proliferate. PBL could not inhibit proliferation of HeLa cells and wild LoVo cells, either. CONCLUSION: The superantigen of TSST-1 regulated dually by 5HRE and CEAp could activate human PBL to kill CEA-positive tumor cells specifically under hypoxia condition.


Subject(s)
Carcinoembryonic Antigen/physiology , Cell Hypoxia/physiology , Enterotoxins/physiology , Lymphocytes/immunology , Promoter Regions, Genetic/genetics , Response Elements/physiology , Superantigens/physiology , Bacterial Toxins/genetics , Carcinoembryonic Antigen/genetics , Cell Hypoxia/genetics , Cell Line, Tumor , Cell Proliferation , Enterotoxins/genetics , HeLa Cells , Humans , Response Elements/genetics , Reverse Transcriptase Polymerase Chain Reaction , Superantigens/genetics , Transfection
18.
J Neuroimmune Pharmacol ; 5(3): 336-54, 2010 Sep.
Article in English | MEDLINE | ID: mdl-20369302

ABSTRACT

Murine coronavirus (mouse hepatitis virus, MHV) is a collection of strains that induce disease in several organ systems of mice. Infection with neurotropic strains JHM and A59 causes acute encephalitis, and in survivors, chronic demyelination, the latter of which serves as an animal model for multiple sclerosis. The MHV receptor is a carcinoembryonic antigen-related cell adhesion molecule, CEACAM1a; paradoxically, CEACAM1a is poorly expressed in the central nervous system (CNS), leading to speculation of an additional receptor. Comparison of highly neurovirulent JHM isolates with less virulent variants and the weakly neurovirulent A59 strain, combined with the use of reverse genetics, has allowed mapping of pathogenic properties to individual viral genes. The spike protein, responsible for viral entry, is a major determinant of tropism and virulence. Other viral proteins, both structural and nonstructural, also contribute to pathogenesis in the CNS. Studies of host responses to MHV indicate that both innate and adaptive responses are crucial to antiviral defense. Type I interferon is essential to prevent very early mortality after infection. CD8 T cells, with the help of CD4 T cells, are crucial for viral clearance during acute disease and persist in the CNS during chronic disease. B cells are necessary to prevent reactivation of virus in the CNS following clearance of acute infection. Despite advances in understanding of coronavirus pathogenesis, questions remain regarding the mechanisms of viral entry and spread in cell types expressing low levels of receptor, as well as the unique interplay between virus and the host immune system during acute and chronic disease.


Subject(s)
Central Nervous System Viral Diseases/virology , Coronavirus Infections/virology , Murine hepatitis virus/pathogenicity , Animals , Brain/virology , Carcinoembryonic Antigen/physiology , Central Nervous System Viral Diseases/immunology , Coronavirus Infections/immunology , Mice , Murine hepatitis virus/genetics , Murine hepatitis virus/immunology , Murine hepatitis virus/physiology , Neuroimmunomodulation/immunology , T-Lymphocytes/immunology , Viral Proteins/genetics , Viral Proteins/physiology , Viral Tropism/physiology
19.
Biorheology ; 46(3): 207-25, 2009.
Article in English | MEDLINE | ID: mdl-19581728

ABSTRACT

The efficiency of secondary tumor establishment is controlled by the ability of tumor cells to withstand a barrage of mechanical and immunological stresses during their passage through the circulatory system. Accumulating evidence suggests that the selectin-dependent interactions of circulating tumor cells with host cells promote their survival and extravasation from the vasculature, therefore representing a critical checkpoint for colonization of distant organs. These observations have motivated the identification and biochemical characterization of functional selectin ligands such as CD44 variant isoforms, carcinoembryonic antigen and podocalyxin-like protein, present on the surface of metastatic colon carcinoma cells. Understanding the molecular underpinnings of selectin-ligand interactions involved in heterotypic tumor cell-host cell adhesion events may provide guidelines for developing novel cancer diagnostics. Recent advancements in diagnostic device fabrication and design integrated with novel biomarkers exploiting the tissue specific biochemistry of malignant versus normal tissue-expressed selectin ligands may hold promise in providing effective alternatives to current cancer diagnostic technologies.


Subject(s)
Biomarkers, Tumor/analysis , Colonic Neoplasms/pathology , Neoplasm Metastasis/diagnosis , Selectins/metabolism , Carcinoembryonic Antigen/physiology , Cell Adhesion/physiology , Humans , Hyaluronan Receptors/physiology , Ligands , Microfluidics/methods , Neoplasm Proteins/physiology , Sialoglycoproteins/physiology
20.
Oncogene ; 27(36): 4943-53, 2008 Aug 21.
Article in English | MEDLINE | ID: mdl-18454175

ABSTRACT

The carcinoembryonic antigen cell adhesion molecule 1 (CEACAM1) is downregulated in colonic and intestinal hyperplastic lesions as well as in other cancers, where it functions as a tumor suppressor. To investigate the functions of CEACAM1 in the normal intestine and in intestinal tumors, we generated a compound knockout mouse model and examined both Ceacam1(-/-) and Apc(1638N/+):Ceacam1(-/-) mice. Ceacam1(-/-) intestinal cells exhibited a significant decrease in apoptosis, with no change in proliferation or migration, however. Compound Apc(1638N/+):Ceacam1(-/-) mice demonstrated an increase in intestinal tumor multiplicity and tumor progression. Increases in intussusceptions and desmoid lesions were also observed. We have shown that CEACAM1-L associates with beta-catenin by co-immunoprecipitation and colocalization in CEACAM1-L-transfected CT26 and CT51 mouse colon carcinoma cells. Ceacam1(-/-) enterocytes displayed decreased glycogen synthase kinase 3-beta activity with corresponding nuclear localization of beta-catenin. Increased T-cell factor/Lef transcriptional activity was observed in CEACAM1-null CT51 colonic cells and in Caco2 colon cancer cells in which CEACAM1 was downregulated. A significant increased expression in c-Myc and cyclin D1 targets of the Wnt signaling pathway was also revealed in the Ceacam1(-/-) intestine. CEACAM1 therefore actively participates in Wnt signaling in intestinal cells and its downregulation in intestinal tissue contributes to malignancy by augmenting tumor multiplicity and progression.


Subject(s)
Carcinoembryonic Antigen/physiology , Intestinal Neoplasms/pathology , Signal Transduction , Wnt Proteins/metabolism , Animals , Base Sequence , Carcinoembryonic Antigen/genetics , Cell Line, Tumor , DNA Primers , Disease Progression , Mice , Mice, Inbred C57BL , Mice, Knockout , Reverse Transcriptase Polymerase Chain Reaction
SELECTION OF CITATIONS
SEARCH DETAIL
...